[(5-chloro-1H-benzimidazol-2-yl)methyl]amine dihydrochloride, 95.0%, 1g

(1S,2R)-(-)-1-Amino-2-indanol>98.0%(GC)(T)5g

4-Hydroxy-6-methyl-nicotinic acid, 97.0%, 1kg

2-Bromo-3-fluoro-6-hydroxybenzaldehyde, 98%, 250mg

Reaction vials ROTILABO® 2 ml, 2 ml, 500 Piece(s)

meso-2,3-Diphenylsuccinonitrile>98.0%(HPLC)5g

Methyl 2-chlorothiazole-5-carboxylate, 95.0%, 5g

4-Chloro-2,3-dihydro-1H-inden-1-amine hydrochloride, 95.0%, 1g

(R)-3-Bromo-piperidine-1-carboxylic acid tert-butyl ester, 5g

tert-Butyl 3-(4-fluorophenyl)-3-oxopropanoate, 95%, 100mg

Sample vials ROTILABO® with short thread ND9, Transparent PP, with graduations, 1.5 ml, 100 Piece(s)

Thiazole-4-carboxamide, 95.0%, 1g

tert-Butyl (5-cyanopyridin-2-yl)carbamate, 95.0%, 5g